{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:15:47Z","timestamp":1777403747283,"version":"3.51.4"},"reference-count":160,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,7,25]],"date-time":"2016-07-25T00:00:00Z","timestamp":1469404800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1136\/annrheumdis-2016-209770","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T00:26:23Z","timestamp":1469492783000},"page":"476-485","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":772,"title":["EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome"],"prefix":"10.1016","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9107-3218","authenticated-orcid":false,"given":"L","family":"Andreoli","sequence":"first","affiliation":[]},{"given":"G K","family":"Bertsias","sequence":"additional","affiliation":[]},{"given":"N","family":"Agmon-Levin","sequence":"additional","affiliation":[]},{"given":"S","family":"Brown","sequence":"additional","affiliation":[]},{"given":"R","family":"Cervera","sequence":"additional","affiliation":[]},{"given":"N","family":"Costedoat-Chalumeau","sequence":"additional","affiliation":[]},{"given":"A","family":"Doria","sequence":"additional","affiliation":[]},{"given":"R","family":"Fischer-Betz","sequence":"additional","affiliation":[]},{"given":"F","family":"Forger","sequence":"additional","affiliation":[]},{"given":"M F","family":"Moraes-Fontes","sequence":"additional","affiliation":[]},{"given":"M","family":"Khamashta","sequence":"additional","affiliation":[]},{"given":"J","family":"King","sequence":"additional","affiliation":[]},{"given":"A","family":"Lojacono","sequence":"additional","affiliation":[]},{"given":"F","family":"Marchiori","sequence":"additional","affiliation":[]},{"given":"P L","family":"Meroni","sequence":"additional","affiliation":[]},{"given":"M","family":"Mosca","sequence":"additional","affiliation":[]},{"given":"M","family":"Motta","sequence":"additional","affiliation":[]},{"given":"M","family":"Ostensen","sequence":"additional","affiliation":[]},{"given":"C","family":"Pamfil","sequence":"additional","affiliation":[]},{"given":"L","family":"Raio","sequence":"additional","affiliation":[]},{"given":"M","family":"Schneider","sequence":"additional","affiliation":[]},{"given":"E","family":"Svenungsson","sequence":"additional","affiliation":[]},{"given":"M","family":"Tektonidou","sequence":"additional","affiliation":[]},{"given":"S","family":"Yavuz","sequence":"additional","affiliation":[]},{"given":"D","family":"Boumpas","sequence":"additional","affiliation":[]},{"given":"A","family":"Tincani","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1136\/annrheumdis-2016-209770_bib1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.berh.2004.01.002","article-title":"New insights into sexual functioning and fertility in rheumatic diseases","volume":"18","author":"\u00d8stensen","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1136\/annrheumdis-2016-209770_bib2","first-page":"959","article-title":"Women's health and fertility, family planning and pregnancy in immune-mediated rheumatic diseases: a report from a south-eastern European Expert Meeting","volume":"32","author":"Ntali","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/annrheumdis-2016-209770_bib3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/acr.22516","article-title":"Proceedings from the American College of Rheumatology Reproductive Health Summit: the management of fertility, pregnancy, and lactation in women with autoimmune and systemic inflammatory diseases","volume":"67","author":"Kavanaugh","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1136\/annrheumdis-2016-209770_bib4","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.autrev.2014.12.011","article-title":"State of the art: reproduction and pregnancy in rheumatic diseases","volume":"14","author":"\u00d8stensen","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1136\/annrheumdis-2016-209770_bib5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/annrheumdis-2014-206350","article-title":"2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations","volume":"74","author":"van der Heijde","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-209770_bib6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1136\/annrheumdis-2016-209770_bib7","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1177\/0961203313501402","article-title":"The effects of lupus and antiphospholipid antibody syndrome on foetal outcomes","volume":"23","author":"Nalli","year":"2014","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2016-209770_bib8","doi-asserted-by":"crossref","first-page":"J197","DOI":"10.1016\/j.jaut.2011.11.010","article-title":"Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome","volume":"38","author":"Andreoli","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1136\/annrheumdis-2016-209770_bib9","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1177\/0961203306071003","article-title":"Drug exposure, pregnancy outcome and fetal and childhood development occurring in the offspring of mothers with systemic lupus erythematosus and other chronic autoimmune diseases","volume":"15","author":"Parke","year":"2006","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2016-209770_bib10","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1177\/0961203314541691","article-title":"Neurodevelopmental disorders in children born to mothers with systemic lupus erythematosus","volume":"23","author":"Vinet","year":"2014","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2016-209770_bib11","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1177\/0961203314538109","article-title":"Children born to SLE and APS mothers","volume":"23","author":"Nalli","year":"2014","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2016-209770_bib12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/annrheumdis-2011-201167","article-title":"European registry of babies born to mothers with antiphospholipid syndrome","volume":"72","author":"Mekinian","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-209770_bib13","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1002\/art.39320","article-title":"Increased risk of autism spectrum disorders in children born to women with systemic lupus erythematosus: results from a large population-based cohort","volume":"67","author":"Vinet","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/annrheumdis-2016-209770_bib14","doi-asserted-by":"crossref","first-page":"e104375","DOI":"10.1371\/journal.pone.0104375","article-title":"Pregnancy-related systemic lupus erythematosus: clinical features, outcome and risk factors of disease flares\u2014a case control study","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1136\/annrheumdis-2016-209770_bib15","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1177\/0961203310397967","article-title":"Predictors of maternal and fetal outcomes in pregnancies of patients with systemic lupus erythematosus","volume":"20","author":"Kwok","year":"2011","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2016-209770_bib16","first-page":"551","article-title":"Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis","volume":"29","author":"Roberge","year":"2012","journal-title":"Am J Perinatol"},{"key":"10.1136\/annrheumdis-2016-209770_bib17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/0961203314551812","article-title":"Renal biopsy in the management of lupus nephritis during pregnancy","volume":"24","author":"Chen","year":"2015","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2016-209770_bib18","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/oxfordjournals.qjmed.a068889","article-title":"Pregnancy and its outcome in systemic lupus erythematosus","volume":"87","author":"Le Thi Huong","year":"1994","journal-title":"QJM"},{"key":"10.1136\/annrheumdis-2016-209770_bib19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.7326\/M14-2235","article-title":"Predictors of pregnancy outcomes in patients with lupus: a cohort study","volume":"163","author":"Buyon","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1136\/annrheumdis-2016-209770_bib20","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/art.20864","article-title":"The impact of increased lupus activity on obstetric outcomes","volume":"52","author":"Clowse","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-209770_bib21","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1136\/ard.2004.022442","article-title":"Clinical predictors of fetal and maternal outcome in Chinese patients with systemic lupus erythematosus","volume":"63","author":"Mok","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-209770_bib22","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.ajog.2005.02.063","article-title":"Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus","volume":"192","author":"Chakravarty","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1136\/annrheumdis-2016-209770_bib23","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/ndt\/gfn348","article-title":"Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome","volume":"24","author":"Imbasciati","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1136\/annrheumdis-2016-209770_bib24","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1177\/0961203310378669","article-title":"Pregnancy outcome in 396 pregnancies in patients with SLE in Saudi Arabia","volume":"19","author":"Al Arfaj","year":"2010","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2016-209770_bib25","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2215\/CJN.00240110","article-title":"A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis","volume":"5","author":"Smyth","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1136\/annrheumdis-2016-209770_bib26","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1136\/ard.51.5.619","article-title":"Risk factors in the pregnancy of patients with systemic lupus erythematosus: association of hypocomplementaemia with poor prognosis","volume":"51","author":"Shibata","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-209770_bib27","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/rheumatology\/41.6.643","article-title":"Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies","volume":"41","author":"Cortes-Hernandez","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2016-209770_bib28","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1182\/blood-2013-08-522623","article-title":"Comparative incidence of pregnancy outcomes in treated obstetric antiphospholipid syndrome: the NOH-APS observational study","volume":"123","author":"Bouvier","year":"2014","journal-title":"Blood"},{"key":"10.1136\/annrheumdis-2016-209770_bib29","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1515\/jpm-2014-0118","article-title":"Neonatal outcome in pregnant patients with antiphospholipid syndrome","volume":"43","author":"Jeremic","year":"2015","journal-title":"J Perinat Med"},{"key":"10.1136\/annrheumdis-2016-209770_bib30","first-page":"1560","article-title":"Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals","volume":"31","author":"Gir\u00f3n-Gonz\u00e1lez","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2016-209770_bib31","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/rheumatology\/ker139","article-title":"Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study","volume":"50","author":"Ruffatti","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2016-209770_bib32","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3899\/jrheum.081194","article-title":"Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus","volume":"36","author":"Danowski","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2016-209770_bib33","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1002\/art.22159","article-title":"Hydroxychloroquine in lupus pregnancy","volume":"54","author":"Clowse","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-209770_bib34","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/art.34402","article-title":"Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies","volume":"64","author":"Lockshin","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-209770_bib35","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1538-7836.2005.01185.x","article-title":"Primary antiphospholipid syndrome in pregnancy: an analysis of outcome in a cohort of 33 women treated with a rigorous protocol","volume":"3","author":"Stone","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1136\/annrheumdis-2016-209770_bib36","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.thromres.2011.02.006","article-title":"The association between antiphospholipid antibodies and placenta mediated complications: a systematic review and meta-analysis","volume":"128","author":"Abou-Nassar","year":"2011","journal-title":"Thromb Res"},{"key":"10.1136\/annrheumdis-2016-209770_bib37","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1538-7836.2010.03747.x","article-title":"Observational study of pregnant women with a previous spontaneous abortion before the 10th gestation week with and without antiphospholipid antibodies","volume":"8","author":"Chauleur","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1136\/annrheumdis-2016-209770_bib38","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/acr.20098","article-title":"Laboratory and clinical features of pregnant women with antiphospholipid syndrome and neonatal outcome","volume":"62","author":"Ruffatti","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1136\/annrheumdis-2016-209770_bib39","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/j.1600-0412.2011.01236.x","article-title":"High positive antibody titers and adverse pregnancy outcome in women with antiphospholipid syndrome","volume":"90","author":"Simchen","year":"2011","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1136\/annrheumdis-2016-209770_bib40","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.111.089268","article-title":"Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA\/Ro-antibody-associated cardiac manifestations of neonatal lupus","volume":"126","author":"Izmirly","year":"2012","journal-title":"Circulation"},{"key":"10.1136\/annrheumdis-2016-209770_bib41","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/1529-0131(200108)44:8<1832::AID-ART320>3.0.CO;2-C","article-title":"Risk of congenital complete heart block in newborns of mothers with anti-Ro\/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women","volume":"44","author":"Brucato","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-209770_bib42","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1067\/mpd.2003.233","article-title":"Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies","volume":"142","author":"Cimaz","year":"2003","journal-title":"J Pediatr"},{"key":"10.1136\/annrheumdis-2016-209770_bib43","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1002\/art.20554","article-title":"Outcome of pregnancies in patients with anti-SSA\/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group","volume":"50","author":"Costedoat-Chalumeau","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-209770_bib44","doi-asserted-by":"crossref","first-page":"e000020","DOI":"10.1136\/lupus-2014-000020","article-title":"Pregnancy outcomes among African-American patients with systemic lupus erythematosus compared with controls","volume":"1","author":"Barnado","year":"2014","journal-title":"Lupus Sci Med"},{"key":"10.1136\/annrheumdis-2016-209770_bib45","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1093\/rheumatology\/kel222","article-title":"Predictors of post-partum damage accrual in systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (XXXVIII)","volume":"45","author":"Andrade","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2016-209770_bib46","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s11255-015-1032-y","article-title":"Clinical outcomes and predictors of fetal and maternal consequences of pregnancy in lupus nephritis patients","volume":"47","author":"Lv","year":"2015","journal-title":"Int Urol Nephrol"},{"key":"10.1136\/annrheumdis-2016-209770_bib47","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ogc.2008.04.003","article-title":"Recurrent risk of adverse pregnancy outcome","volume":"35","author":"Moore","year":"2008","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1136\/annrheumdis-2016-209770_bib48","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12026-014-8572-6","article-title":"Predictors of maternal and fetal complications in SLE patients: a prospective study","volume":"60","author":"Borella","year":"2014","journal-title":"Immunol Res"},{"key":"10.1136\/annrheumdis-2016-209770_bib49","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1191\/0961203305lu2072oa","article-title":"Maternal and fetal outcome of lupus pregnancy: a prospective study of 29 pregnancies","volume":"14","author":"Molad","year":"2005","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2016-209770_bib50","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1177\/0961203310394894","article-title":"Thyroid disease in pregnant women with systemic lupus erythematosus: increased preterm delivery","volume":"20","author":"Stagnaro-Green","year":"2011","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2016-209770_bib51","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1136\/annrheumdis-2011-201210","article-title":"Second pregnancy outcomes for women with systemic lupus erythematosus","volume":"72","author":"Shand","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-209770_bib52","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.3899\/jrheum.100997","article-title":"Pregnancy outcomes in systemic lupus erythematosus with and without previous nephritis","volume":"38","author":"Bramham","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2016-209770_bib53","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-209770_bib54","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.autrev.2014.12.010","article-title":"The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): a survey of 247 consecutive cases","volume":"14","author":"Alijotas-Reig","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1136\/annrheumdis-2016-209770_bib55","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.2165\/11635030-000000000-00000","article-title":"Efficacy and safety of mycophenolate mofetil versus cyclophosphamide for induction therapy of lupus nephritis: a meta-analysis of randomized controlled trials","volume":"72","author":"Liu","year":"2012","journal-title":"Drugs"},{"key":"10.1136\/annrheumdis-2016-209770_bib56","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/0961203314555352","article-title":"Hydroxychloroquine and pregnancy on lupus flares in Korean patients with systemic lupus erythematosus","volume":"24","author":"Koh","year":"2015","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2016-209770_bib57","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1177\/0961203308097575","article-title":"Maternal and foetal outcomes in pregnant patients with active lupus nephritis","volume":"18","author":"Wagner","year":"2009","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2016-209770_bib58","first-page":"2127","article-title":"Preterm deliveries in women with systemic lupus erythematosus","volume":"30","author":"Clark","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2016-209770_bib59","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/rheumatology\/kes425","article-title":"Low risk of renal flares and negative outcomes in women with lupus nephritis conceiving after switching from mycophenolate mofetil to azathioprine","volume":"52","author":"Fischer-Betz","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2016-209770_bib60","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1191\/096120301678646137","article-title":"Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study","volume":"10","author":"Levy","year":"2001","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2016-209770_bib61","unstructured":"WHO Guidelines Approved by the Guidelines Review Committee. Medical Eligibility Criteria for Contraceptive Use: A WHO Family Planning Cornerstone. Geneva: World Health Organization, 2010. http:\/\/apps.who.int\/iris\/bitstream\/10665\/181468\/1\/9789241549158_eng.pdf"},{"key":"10.1136\/annrheumdis-2016-209770_bib62","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1177\/0961203306071706","article-title":"Treatment of menorrhagia associated with oral anticoagulation: efficacy and safety of the levonorgestrel releasing intrauterine device (Mirena coil)","volume":"15","author":"Pisoni","year":"2006","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2016-209770_bib63","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1056\/NEJMoa051135","article-title":"Combined oral contraceptives in women with systemic lupus erythematosus","volume":"353","author":"Petri","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1136\/annrheumdis-2016-209770_bib64","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1056\/NEJMoa050817","article-title":"A trial of contraceptive methods in women with systemic lupus erythematosus","volume":"353","author":"S\u00e1nchez-Guerrero","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1136\/annrheumdis-2016-209770_bib65","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S1474-4422(09)70239-X","article-title":"Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study","volume":"8","author":"Urbanus","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1136\/annrheumdis-2016-209770_bib66","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/acr.21593","article-title":"Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus","volume":"64","author":"Clowse","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1136\/annrheumdis-2016-209770_bib67","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/03009740902763099","article-title":"Reproductive health in women with systemic lupus erythematosus compared to population controls","volume":"38","author":"Ekblom-Kullberg","year":"2009","journal-title":"Scand J Rheumatol"},{"key":"10.1136\/annrheumdis-2016-209770_bib68","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1210\/jc.2013-1235","article-title":"Study of anti-M\u00fcllerian hormone and its relation to the subsequent probability of pregnancy in 112 patients with systemic lupus erythematosus, exposed or not to cyclophosphamide","volume":"98","author":"Morel","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1136\/annrheumdis-2016-209770_bib69","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.reuma.2014.03.009","article-title":"Anti-M\u00fcllerian hormone in reproductive age women with systemic lupus erythematosus","volume":"11","author":"Velarde-Ochoa Mdel","year":"2015","journal-title":"Reumatol Clin"},{"key":"10.1136\/annrheumdis-2016-209770_bib70","doi-asserted-by":"crossref","first-page":"366","DOI":"10.7326\/0003-4819-119-5-199309010-00003","article-title":"Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy","volume":"119","author":"Boumpas","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1136\/annrheumdis-2016-209770_bib71","first-page":"2129","article-title":"Predictors of sustained amenorrhea from pulsed intravenous cyclophosphamide in premenopausal women with systemic lupus erythematosus","volume":"29","author":"Ioannidis","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2016-209770_bib72","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/ard.2008.102533","article-title":"The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide","volume":"69","author":"Houssiau","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-209770_bib73","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.fertnstert.2015.03.019","article-title":"Diagnostic evaluation of the infertile female: a committee opinion","volume":"103","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1136\/annrheumdis-2016-209770_bib74","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1177\/0961203312442753","article-title":"Fertility preservation methods in young women with systemic lupus erythematosus prior to cytotoxic therapy: experiences from the FertiPROTEKT network","volume":"21","author":"Henes","year":"2012","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2016-209770_bib75","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/rheumatology\/ken293","article-title":"Fertility preservation treatment for young women with autoimmune diseases facing treatment with gonadotoxic agents","volume":"47","author":"Elizur","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2016-209770_bib76","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s10549-010-0996-7","article-title":"Pharmacological interventions for fertility preservation during chemotherapy: a systematic review and meta-analysis","volume":"122","author":"Ben-Aharon","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1136\/annrheumdis-2016-209770_bib77","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1634\/theoncologist.2015-0223","article-title":"Gonadotropin-releasing hormone agonist cotreatment during chemotherapy may increase pregnancy rate in survivors","volume":"20","author":"Blumenfeld","year":"2015","journal-title":"Oncologist"},{"key":"10.1136\/annrheumdis-2016-209770_bib78","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1056\/NEJMoa1413204","article-title":"Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy","volume":"372","author":"Moore","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1136\/annrheumdis-2016-209770_bib79","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/art.39024","article-title":"Randomized, double-blind, dose-escalation trial of triptorelin for ovary protection in childhood-onset systemic lupus erythematosus","volume":"67","author":"Brunner","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/annrheumdis-2016-209770_bib80","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/1529-0131(200003)43:3<550::AID-ANR10>3.0.CO;2-Y","article-title":"Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome","volume":"43","author":"Guballa","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-209770_bib81","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1053\/sarh.2002.37212","article-title":"Importance of planning ovulation induction therapy in systemic lupus erythematosus and antiphospholipid syndrome: a single center retrospective study of 21 cases and 114 cycles","volume":"32","author":"Huong","year":"2002","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-209770_bib82","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3109\/01443615.2012.693986","article-title":"Subfertility treatment in women with systemic lupus erythematosus","volume":"32","author":"Ragab","year":"2012","journal-title":"J Obstet Gynaecol"},{"key":"10.1136\/annrheumdis-2016-209770_bib83","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.revmed.2014.08.004","article-title":"[In vitro fertilization and systemic lupus erythematosus or antiphospholipid syndrome: an update]","volume":"36","author":"Orquevaux","year":"2015","journal-title":"Rev Med Interne"},{"key":"10.1136\/annrheumdis-2016-209770_bib84","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.fertnstert.2009.06.033","article-title":"Ovarian stimulation for ovulation induction and in vitro fertilization in patients with systemic lupus erythematosus and antiphospholipid syndrome","volume":"92","author":"Bellver","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1136\/annrheumdis-2016-209770_bib85","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/art.20081","article-title":"Measuring systemic lupus erythematosus activity during pregnancy: validation of the lupus activity index in pregnancy scale","volume":"51","author":"Ruiz-Irastorza","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-209770_bib86","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1093\/rheumatology\/kes158","article-title":"The BILAG2004-Pregnancy index is reliable for assessment of disease activity in pregnant SLE patients","volume":"51","author":"Yee","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2016-209770_bib87","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.berh.2004.02.012","article-title":"Pregnancy and autoimmune diseases","volume":"18","author":"Gordon","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1136\/annrheumdis-2016-209770_bib88","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0002-9343(86)90251-2","article-title":"Serum complement values (C3 and C4) to differentiate between systemic lupus activity and pre-eclampsia","volume":"81","author":"Buyon","year":"1986","journal-title":"Am J Med"},{"key":"10.1136\/annrheumdis-2016-209770_bib89","first-page":"275","article-title":"Levels of lupus autoantibodies in pregnant SLE patients: correlations with disease activity and pregnancy outcome","volume":"14","author":"Tomer","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/annrheumdis-2016-209770_bib90","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3899\/jrheum.100746","article-title":"The clinical utility of measuring complement and anti-dsDNA antibodies during pregnancy in patients with systemic lupus erythematosus","volume":"38","author":"Clowse","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2016-209770_bib91","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1600-0897.1999.tb00479.x","article-title":"Hypocomplementemia correlates with intrauterine growth retardation in systemic lupus erythematosus","volume":"42","author":"Kobayashi","year":"1999","journal-title":"Am J Reprod Immunol"},{"key":"10.1136\/annrheumdis-2016-209770_bib92","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1136\/annrheumdis-2012-202449","article-title":"Predictors of preterm birth in patients with mild systemic lupus erythematosus","volume":"72","author":"Clowse","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-209770_bib93","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/uog.13190","article-title":"Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE)","volume":"42","author":"Lees","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1136\/annrheumdis-2016-209770_bib94","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(14)62049-3","article-title":"2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial","volume":"385","author":"Lees","year":"2015","journal-title":"Lancet"},{"key":"10.1136\/annrheumdis-2016-209770_bib95","first-page":"CD007529","article-title":"Fetal and umbilical Doppler ultrasound in high-risk pregnancies","volume":"11","author":"Alfirevic","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1136\/annrheumdis-2016-209770_bib96","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/uog.14714","article-title":"An integrated model with classification criteria to predict small-for-gestational-age fetuses at risk of adverse perinatal outcome","volume":"45","author":"Figueras","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1136\/annrheumdis-2016-209770_bib97","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/S0140-6736(15)00131-2","article-title":"Screening for fetal growth restriction with universal third trimester ultrasonography in nulliparous women in the Pregnancy Outcome Prediction (POP) study: a prospective cohort study","volume":"386","author":"Sovio","year":"2015","journal-title":"Lancet"},{"key":"10.1136\/annrheumdis-2016-209770_bib98","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrrheum.2015.29","article-title":"The clinical spectrum of autoimmune congenital heart block","volume":"11","author":"Brito-Zer\u00f3n","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"10.1136\/annrheumdis-2016-209770_bib99","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/CRD.0000000000000026","article-title":"Prevention and treatment in utero of autoimmune-associated congenital heart block","volume":"22","author":"Saxena","year":"2014","journal-title":"Cardiol Rev"},{"key":"10.1136\/annrheumdis-2016-209770_bib100","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.amjcard.2008.12.027","article-title":"Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study","volume":"103","author":"Friedman","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1136\/annrheumdis-2016-209770_bib101","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/CIRCULATIONAHA.111.033894","article-title":"Maternal and fetal factors associated with mortality and morbidity in a multi-racial\/ethnic registry of anti-SSA\/Ro-associated cardiac neonatal lupus","volume":"124","author":"Izmirly","year":"2011","journal-title":"Circulation"},{"key":"10.1136\/annrheumdis-2016-209770_bib102","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1161\/CIRCULATIONAHA.111.041970","article-title":"Isolated atrioventricular block in the fetus: a retrospective, multinational, multicenter study of 175 patients","volume":"124","author":"Eliasson","year":"2011","journal-title":"Circulation"},{"key":"10.1136\/annrheumdis-2016-209770_bib103","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.autrev.2015.08.005","article-title":"Description of 214 cases of autoimmune congenital heart block: Results of the French neonatal lupus syndrome","volume":"14","author":"Levesque","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1136\/annrheumdis-2016-209770_bib104","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1136\/annrheumdis-2015-208311","article-title":"Assessment of fluorinated steroids to avert progression and mortality in anti-SSA\/Ro-associated cardiac injury limited to the fetal conduction system","volume":"75","author":"Izmirly","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-209770_bib105","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1177\/0961203315593171","article-title":"Ro\/SSA autoantibody-positive pregnancy: reactions to serial fetal Doppler echocardiographic surveillance","volume":"24","author":"Tingstr\u00f6m","year":"2015","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2016-209770_bib106","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/096120339400300304","article-title":"Pregnancy in systemic lupus erythematosus: a prospective study","volume":"3","author":"Derksen","year":"1994","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2016-209770_bib107","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/acr.22364","article-title":"Switching treatment between mycophenolate mofetil and azathioprine in lupus patients: indications and outcomes","volume":"66","author":"Al Maimouni","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1136\/annrheumdis-2016-209770_bib108","first-page":"160","article-title":"Cyclosporine in the treatment of lupus nephritis including two patients treated during pregnancy","volume":"40","author":"Hussein","year":"1993","journal-title":"Clin Nephrol"},{"key":"10.1136\/annrheumdis-2016-209770_bib109","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1177\/0961203314540353","article-title":"Tacrolimus is an effective treatment for lupus nephritis in pregnancy","volume":"23","author":"Webster","year":"2014","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2016-209770_bib110","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/ajkd.2002.35678","article-title":"Pregnancy in lupus nephritis","volume":"40","author":"Moroni","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1136\/annrheumdis-2016-209770_bib111","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","article-title":"The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation","volume":"75","author":"G\u00f6testam Skorpen","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-209770_bib112","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.transci.2010.05.002","article-title":"Successful prevention of thrombotic thrombocytopenic purpura (TTP) relapse using monthly prophylactic plasma exchanges throughout pregnancy in a patient with systemic lupus erythematosus and a prior history of refractory TTP and recurrent fetal loss","volume":"43","author":"Abou-Nassar","year":"2010","journal-title":"Transfus Apher Sci"},{"key":"10.1136\/annrheumdis-2016-209770_bib113","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1046\/j.1526-0968.2001.005001022.x","article-title":"Successful delivery in a pregnant woman with lupus anticoagulant positive systemic lupus erythematosus treated with double filtration plasmapheresis","volume":"5","author":"Takeshita","year":"2001","journal-title":"Ther Apher"},{"key":"10.1136\/annrheumdis-2016-209770_bib114","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10067-007-0649-3","article-title":"Maternal and fetal outcomes of 72 pregnancies in Argentine patients with systemic lupus erythematosus (SLE)","volume":"27","author":"Cavallasca","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1136\/annrheumdis-2016-209770_bib115","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.semarthrit.2014.05.006","article-title":"Use of belimumab throughout pregnancy to treat active systemic lupus erythematosus: a case report","volume":"44","author":"Danve","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-209770_bib116","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.coph.2013.03.004","article-title":"How safe are anti-rheumatic drugs during pregnancy?","volume":"13","author":"\u00d8stensen","year":"2013","journal-title":"Curr Opin Pharmacol"},{"key":"10.1136\/annrheumdis-2016-209770_bib117","article-title":"BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids","author":"Flint","year":"2016","journal-title":"Rheumatology"},{"key":"10.1136\/annrheumdis-2016-209770_bib118","article-title":"BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part II: analgesics and other drugs used in rheumatology practice","author":"Flint","year":"2016","journal-title":"Rheumatology"},{"key":"10.1136\/annrheumdis-2016-209770_bib119","doi-asserted-by":"crossref","first-page":"273.e1","DOI":"10.1016\/j.ajog.2015.09.078","article-title":"The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies","volume":"214","author":"Sciascia","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1136\/annrheumdis-2016-209770_bib120","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1160\/th15-06-0491","article-title":"The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgment","volume":"115","author":"Sciascia","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1136\/annrheumdis-2016-209770_bib121","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.autrev.2015.01.012","article-title":"The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: data from a European multicenter retrospective study","volume":"14","author":"Mekinian","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1136\/annrheumdis-2016-209770_bib122","doi-asserted-by":"crossref","first-page":"64.e1","DOI":"10.1016\/j.ajog.2012.09.020","article-title":"Maternal autoantibody levels in congenital heart block and potential prophylaxis with antiinflammatory agents","volume":"208","author":"Tunks","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1136\/annrheumdis-2016-209770_bib123","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000336662","article-title":"Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis","volume":"31","author":"Roberge","year":"2012","journal-title":"Fetal Diagn Ther"},{"issue":"1","key":"10.1136\/annrheumdis-2016-209770_bib124","doi-asserted-by":"crossref","first-page":"178s","DOI":"10.1097\/01.AOG.0000447195.12926.b9","article-title":"The medical management of antiphospholipid syndrome in pregnancy: a meta-analysis","volume":"123","author":"Wu","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1136\/annrheumdis-2016-209770_bib125","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/rheumatology\/kep373","article-title":"Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression","volume":"49","author":"Mak","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2016-209770_bib126","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/AOG.0b013e3181deba40","article-title":"Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis","volume":"115","author":"Ziakas","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1136\/annrheumdis-2016-209770_bib127","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11926-013-0403-6","article-title":"Pregnancy morbidity in antiphospholipid syndrome: what is the impact of treatment?","volume":"16","author":"de Jes\u00fas","year":"2014","journal-title":"Curr Rheumatol Rep"},{"key":"10.1136\/annrheumdis-2016-209770_bib128","first-page":"551","article-title":"Adjusted prophylactic doses of nadroparin plus low dose aspirin therapy in obstetric antiphospholipid syndrome. A prospective cohort management study","volume":"29","author":"Ruffatti","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/annrheumdis-2016-209770_bib129","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ijgo.2010.09.010","article-title":"Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome","volume":"112","author":"Fouda","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/annrheumdis-2016-209770_bib130","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1160\/TH14-03-0191","article-title":"Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study","volume":"112","author":"Ruffatti","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1136\/annrheumdis-2016-209770_bib131","doi-asserted-by":"crossref","first-page":"6948","DOI":"10.1182\/blood-2011-02-339234","article-title":"First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss","volume":"117","author":"Bramham","year":"2011","journal-title":"Blood"},{"key":"10.1136\/annrheumdis-2016-209770_bib132","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1177\/0961203312451335","article-title":"Pregnancy outcome in patients with antiphospholipid syndrome after cerebral ischaemic events: an observational study","volume":"21","author":"Fischer-Betz","year":"2012","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2016-209770_bib133","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/ard.2003.019000","article-title":"The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women","volume":"64","author":"Le Thi Thuong","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1136\/annrheumdis-2016-209770_bib134","doi-asserted-by":"crossref","first-page":"953","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00004","article-title":"The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial","volume":"142","author":"Buyon","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1136\/annrheumdis-2016-209770_bib135","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1002\/art.22855","article-title":"Menopause hormonal therapy in women with systemic lupus erythematosus","volume":"56","author":"S\u00e1nchez-Guerrero","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-209770_bib136","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/acr.20608","article-title":"Efficacy of estrogen plus progestin on menopausal symptoms in women with systemic lupus erythematosus: a randomized, double-blind, controlled trial","volume":"63","author":"Cravioto","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1136\/annrheumdis-2016-209770_bib137","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/0961203308097475","article-title":"Hormone replacement therapy in women with systemic lupus erythematosus and risk of cardiovascular disease","volume":"18","author":"Hochman","year":"2009","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2016-209770_bib138","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/RHU.0b013e318156bbf5","article-title":"Systemic lupus erythematosus in a multiethnic US cohort (LUMINA L II): relationship between vascular events and the use of hormone replacement therapy in postmenopausal women","volume":"13","author":"Fernandez","year":"2007","journal-title":"J Clin Rheumatol"},{"key":"10.1136\/annrheumdis-2016-209770_bib139","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.clinthera.2015.06.006","article-title":"The pathophysiology and treatment of osteoporosis","volume":"37","author":"Drake","year":"2015","journal-title":"Clin Ther"},{"key":"10.1136\/annrheumdis-2016-209770_bib140","doi-asserted-by":"crossref","first-page":"h5746","DOI":"10.1136\/bmj.h5746","article-title":"Diagnosis and management of menopause: summary of NICE guidance","volume":"351","author":"Sarri","year":"2015","journal-title":"BMJ"},{"key":"10.1136\/annrheumdis-2016-209770_bib141","unstructured":"National Collaborating Centre for Ws, Children's H. National Institute for Health and Clinical Excellence: Guidance. Menopause: Full Guideline. London: National Institute for Health and Care Excellence (UK) Copyright (c) 2015 National Collaborating Centre for Women's and Children's Health, 2015. https:\/\/www.nice.org.uk\/guidance\/ng23\/evidence\/appendices-ag-559549262"},{"key":"10.1136\/annrheumdis-2016-209770_bib142","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1038\/bjc.2011.115","article-title":"Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis","volume":"104","author":"Bernatsky","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1136\/annrheumdis-2016-209770_bib143","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jaut.2012.12.009","article-title":"Cancer risk in systemic lupus: an updated international multi-centre cohort study","volume":"42","author":"Bernatsky","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1136\/annrheumdis-2016-209770_bib144","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/rheumatology\/keq304","article-title":"Meta-analysis of systemic lupus erythematosus and the risk of cervical neoplasia","volume":"50","author":"Liu","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2016-209770_bib145","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s10067-010-1606-0","article-title":"Systemic lupus erythematosus, human papillomavirus infection, cervical pre-malignant and malignant lesions: a systematic review","volume":"30","author":"Santana","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1136\/annrheumdis-2016-209770_bib146","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.autrev.2014.03.001","article-title":"Increased risk of high grade cervical squamous intraepithelial lesions in systemic lupus erythematosus: a meta-analysis of the literature","volume":"13","author":"Zard","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1136\/annrheumdis-2016-209770_bib147","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1002\/art.30483","article-title":"High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort","volume":"63","author":"Dreyer","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-209770_bib148","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1177\/096120330000900711","article-title":"Increased cervical dysplasia in intravenous cyclophosphamide-treated patients with SLE: a preliminary study","volume":"9","author":"Bateman","year":"2000","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2016-209770_bib149","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/rheumatology\/keh331","article-title":"Factors associated with abnormal Pap results in systemic lupus erythematosus","volume":"43","author":"Bernatsky","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2016-209770_bib150","first-page":"1763","article-title":"Increased incidence of cervical intraepithelial neoplasia in women with systemic lupus erythematosus treated with intravenous cyclophosphamide","volume":"31","author":"Ognenovski","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2016-209770_bib151","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/RHU.0b013e3181df5261","article-title":"Is higher prevalence of cervical intraepithelial neoplasia in women with lupus due to immunosuppression?","volume":"16","author":"Klumb","year":"2010","journal-title":"J Clin Rheumatol"},{"key":"10.1136\/annrheumdis-2016-209770_bib152","first-page":"45","article-title":"Cancer screening in patients with systemic lupus erythematosus","volume":"33","author":"Bernatsky","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2016-209770_bib153","doi-asserted-by":"crossref","first-page":"R84","DOI":"10.1186\/ar3011","article-title":"Provision of preventive health care in systemic lupus erythematosus: data from a large observational cohort study","volume":"12","author":"Yazdany","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/annrheumdis-2016-209770_bib154","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/jama.2009.1201","article-title":"Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine","volume":"302","author":"Slade","year":"2009","journal-title":"JAMA"},{"key":"10.1136\/annrheumdis-2016-209770_bib155","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1546-0096-11-29","article-title":"Safety and immunogenicity of the quadrivalent HPV vaccine in female Systemic Lupus Erythematosus patients aged 12 to 26 years","volume":"11","author":"Soybilgic","year":"2013","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1136\/annrheumdis-2016-209770_bib156","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/annrheumdis-2012-201393","article-title":"Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case-control study","volume":"72","author":"Mok","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-209770_bib157","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/0961203311429556","article-title":"Systemic lupus erythematosus following HPV immunization or infection?","volume":"21","author":"Soldevilla","year":"2012","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2016-209770_bib158","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s10067-013-2266-7","article-title":"Human papillomavirus vaccine and systemic lupus erythematosus","volume":"32","author":"Gatto","year":"2013","journal-title":"Clin Rheumatol"},{"key":"10.1136\/annrheumdis-2016-209770_bib159","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1517\/14740338.2015.1073710","article-title":"The safety of human papilloma virus-blockers and the risk of triggering autoimmune diseases","volume":"14","author":"Baker","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"10.1136\/annrheumdis-2016-209770_bib160","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/ard.2010.137216","article-title":"EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"70","author":"van Assen","year":"2011","journal-title":"Ann Rheum Dis"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724028322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724028322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/annrheumdis-2016-209770","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T08:34:43Z","timestamp":1739522083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724028322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":160,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0003496724028322"],"URL":"https:\/\/doi.org\/10.1136\/annrheumdis-2016-209770","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/annrheumdis-2016-209770","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Published by Elsevier Inc. For permission to use (where not already granted under a licence) please go to http:\/\/www.bmj.com\/company\/products-services\/rights-and-licensing. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}